EG

[Leronlimab @Cytodyn2026]

@GloboNews https://t.co/M2CpEqpW7V

[EG @egold54]

Looking forward to the mCNC data.

#Leronliamb

@Cytodyn2026

[Natera @NateraGenetics]

New insights emerge when therapeutic innovation and diagnostic innovation work hand in hand.

Through our collaboration with CytoDyn, Signatera™ will be used to evaluate molecular response patterns associated with leronlimab treatment in metastatic colorectal cancer. Natera will also contribute real-world data insights leveraging our proprietary oncology database, which includes more than 2 million plasma timepoints and enriched clinical and imaging data.

We are pleased to partner with CytoDyn as it advances the development of leronlimab. Together, we aim to generate evidence that may help inform drug development and advance our understanding of treatment response. Most importantly, every new insight has the potential to bring us closer to better outcomes for patients. https://t.co/EXiOBw08VJ

[Leronlimab @Cytodyn2026]

@markets https://t.co/M2CpEqpW7V

[EG @egold54]

$CYDY
Natera and CytoDyn Announce Strategic Collaboration to Advance ctDNA-Guided Development and Molecular Response Analysis in Metastatic Colorectal Cancer

https://t.co/1vjGrz79C2

#Leronliamb is changing the lives of many patients.

https://t.co/jwybCARq5p

#Oncology

[EG @egold54]

Safety and 5-year survival following treatment with leronlimab plus physician’s choice combination therapy in patients with metastatic triple-negative breast cancer.

https://t.co/FBjjzSr8Rr

https://t.co/jwybCARq5p

#oncology
#TNBC
#ASCO
#Leronliamb
#CancerResearch

[EG @egold54]

Leronlimab in combination with trifluridine/tipiracil (TAS-102) plus bevacizumab for patients with refractory metastatic colorectal cancer (mCRC): The phase 2 CLOVER study.

https://t.co/jwybCARq5p

https://t.co/3ZpJTFMHah

#oncology
#mCRC
#leronliamb
#colonrectalcancer

[EG @egold54]

$CYDY

A lot going on for this biotech company.

#InvestingStrategy
#stocks
#leronliamb

[Leronlimab @Cytodyn2026]

Robert Hoffman (CEO) last weeks presentation. Start at 3 minute. https://t.co/Z2lvB7mOxj

[EG @egold54]

$CYDY

This small biotech company changes people's health for the better. It will change people's bank account for the better.

Do your DD on https://t.co/jwybCARq5p

#stocks
#stockstowatch
#oncology
#ccr5
#cancer

[Leronlimab @Cytodyn2026]

https://t.co/CFllksd1GB

[EG @egold54]

$CYDY

[Leronlimab @Cytodyn2026]

https://t.co/K9Shrx9Fag

[EG @egold54]

$CYDY

Tick Tock

[Leronlimab @Cytodyn2026]

https://t.co/H3cmdJ3Wbg

[EG @egold54]

$CYDY
#Leronlimab in combination with trifluridine/tipiracil (TAS-102) plus bevacizumab for patients with refractory metastatic colorectal cancer (mCRC): The phase 2 CLOVER study.

https://t.co/nV23mYeyN4

#Oncology
#Coloncancer
#Breastcancer
#HIV

https://t.co/jwybCARq5p

[EG @egold54]

$CYDY

Safety and 5-year survival following treatment with leronlimab plus physician’s choice combination therapy in patients with metastatic triple-negative breast cancer.

https://t.co/FBjjzSr8Rr

#Oncology
#Leronliamb
#breastcancer
#coloncancer
https://t.co/jwybCARq5p

[EG @egold54]

Keep a close eye on $CYDY

So many patients to help live a longer and more fruitful life. let's make some money also
#cancer
#breastcancer
#coloncancer
#liverfibrosis
#glioblastoma
#HIV

Just a taste

https://t.co/mZc2STcIZH

[Leronlimab @Cytodyn2026]

Clover Trial Update

https://t.co/p07tpaP71n

[EG @egold54]

$CYDY

Leronlimab has so many uses to help so many in need.

#buyout
#partnership
#cancer
#hiv

[Leronlimab @Cytodyn2026]

https://t.co/UYRrMEkCL2,

[EG @egold54]

$CYDY
Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease (SALIENT-AD)
https://t.co/dXr5sjKktU

https://t.co/jwybCARq5p

#Alzheimers
#CCR5
#cancer
#HIV

[Leronlimab @Cytodyn2026]

https://t.co/SmgXF6LHOD

[EG @egold54]

$CYDY

Congrats! Cytodyn is a totally different company since Dr. Jacob Lalezari became CEO in 2024. #Leronliamb is going to continue to help the most sick with tNBC and mCRC not to mention HIV. New studies for liver fibrosis and cognitive disorders.
#CCR5
#biotech

[Leronlimab @Cytodyn2026]

New Leronlimab Patent Dated May 12th ! 2026

[EG @egold54]

$CYDY

May 12th 2026 Cytodyn receives a patent for methods for treating metastatic colon cancer with #CCR5 blocking #Leronliamb.

More information at https://t.co/jwybCARq5p

#Coloncancer
#Breastcancer
#HIV
#Alzheimer

[EG @egold54]

$CYDY
4/30/26 investor webinar
https://t.co/KwoXYbzLA5

A lot of good things happening for this CCR5 blocker, #Leronlimab. It deserves a listen!
https://t.co/jwybCARXUX
#StockFocusnews
#biotech
#HIV
#coloncancer
#breastcancer
#alzheimers

[EG @egold54]

$CYDY
CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities.
https://t.co/fAPrA2KkHU

https://t.co/jwybCARq5p

#Leronliamb
#cancer
#StockFocusnews